miR-3613-5p通过准和调节XPO6来促进肺癌的进展
Xingya Wang1, Huichao Li2, Xianzhen Wu3
1Department of Respiratory and Critical Care Medicine, Chongqing Southwest Aluminium Hospital, Chongqing, 401326, China.
Discover oncology
|December 11, 2025
概括
微RNA 3613-5p (miR-3613-5p) 在肺癌 (LC) 中过度表达,并预测生存率差. 针对miR-3613-5p-XPO6通路可能为LC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 微RNAs (miRNAs) 在肺癌 (LC) 的发展和进展中发挥着关键作用.
- miRNAs被认为是各种癌症的潜在预后生物标志物,包括LC.
研究的目的:
- 为了研究miR-3613-5p在肺癌中的预后意义.
- 在LC中阐明miR-3613-5p及其点基因XPO6之间的调控关系.
- 探索miR-3613-5p-XPO6轴作为肺癌治疗点的潜力.
主要方法:
- 使用定量实时PCR (qRT-PCR) 来测量miR-3613-5p和XPO6.6的表达水平.
- 生物信息预测 (miRDB) 和双露西法酶记者测试被用于确认miR-3613-5p和XPO6.6之间的相互作用.
- 进行了细胞增殖,迁移和入侵试验 (CCK-8,Transwell),以评估miR-3613-5p的功能影响.
主要成果:
- 发现miR-3613-5p在肺癌组织中显著过度表达.
- 高的miR-3613-5p表达与吸烟史,晚期TNM阶段,较大的瘤大小,淋巴结转移以及较差的患者存活率相关.
- miR-3613-5p被确定为LC的独立预后因素,直接准XPO6,XPO6部分抵消了miR-3613-5p的前瘤效应.
结论:
- 该miR-3613-5p-XPO6信号通路与肺癌进展有关.
- 这一轴代表了开发肺癌新型治疗策略的有希望的治疗目标.
相关概念视频
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs
23.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Induced Pluripotent Stem Cells
5.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.3K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


